AIM ImmunoTech Inc. (AIM) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Aim Immunotech Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.000 -- 00:00:05.400 Hello and welcome to the AIM Immunotech fourth quarter and full year 2024 Update Conference 00:00:05.400 -- 00:00:07.400 Call and Webcast. 00:00:07.400 -- 00:00:11.740 As a brief reminder, all participants are currently in a listen-only mode. 00:00:11.740 -- 00:00:16.520 If anyone requires operator assistance during the event, please press star zero on your 00:00:16.520 -- 00:00:18.680 telephone keypad. 00:00:18.680 -- 00:00:22.200 Following the presentation will be a question and answer session. 00:00:22.200 -- 00:00:26.560 Note that this webcast is being recorded at the company's request and a replay will be 00:00:26.560 -- 00:00:30.840 the company's website following the end of the event. 00:00:30.840 -- 00:00:34.000 At this time, I would like to remind our listeners that remarks made during the webcast 00:00:34.000 -- 00:00:38.920 may state management's intentions, beliefs, expectations, or future projections. 00:00:38.920 -- 00:00:42.760 These are forward-looking statements that involve risks and uncertainties. 00:00:42.760 -- 00:00:45.980 Forward-looking statements on this call are made pursuant to the safe harbor provisions 00:00:45.980 -- 00:00:50.560 of the Federal Securities Law Center based on AIM Immunotech's current expectations and 00:00:50.560 -- 00:00:52.880 actual results for different materiality. 00:00:52.880 -- 00:00:57.960 As a result, you should not place undue reliance on any forward-looking statements. 00:00:57.960 -- 00:01:01.440 Some of the factors that could cause actual results of different materiality from these 00:01:01.440 -- 00:01:06.280 contemplated by such forward-looking statements are discussed in the periodic reports 00:01:06.280 -- 00:01:10.760 in immunotech files with the Securities and Exchan...